Vir Biotechnology, Inc.
VIR
$4.60
$0.225.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.27% | -15.66% | 51.06% | -54.44% | -111.99% |
| Total Depreciation and Amortization | 1.74% | -0.66% | -0.35% | -32.02% | -5.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.47% | -55.19% | 42.21% | -62.29% | 72.87% |
| Change in Net Operating Assets | -196.17% | 253.28% | -197.19% | 1,149.37% | 97.97% |
| Cash from Operations | -53.90% | 10.86% | 48.89% | -120.28% | 28.84% |
| Capital Expenditure | -55.80% | 32.32% | -2.16% | -253.75% | 64.42% |
| Sale of Property, Plant, and Equipment | -83.99% | -88.55% | 49,000.00% | -98.68% | -28.89% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -54.01% | -8.90% | 16.32% | -42.92% | 612.03% |
| Cash from Investing | -55.48% | -9.89% | 18.66% | -43.95% | 644.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 545.00% | -157.97% | 200.00% |
| Issuance of Common Stock | 302.34% | -52.16% | 1,660.56% | -97.64% | 1,262.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 242.14% | -52.65% | 3,974.19% | -98.95% | 1,835.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.19% | -9.32% | 202.87% | -138.66% | 269.15% |